This was a minor analysis of a randomised controlled trial. The journalist have already published the grades of their prevalent trial, which look at the preventive effects of calcium supplementation on bone solidity and fracture rates in on top form women after the menopause. During that trial and before the analysis of any facts on heart disease or finger, they write a detailed propose of their intention to narrative the data in preference of this on track analysis.
[6] Sica D, Gradman AH, Lederballe O, et al. Aliskiren, a anti-government renin inhibitor, is resourcefully tolerate and have sustained BP-lowering effects alone or in coupling with HCTZ during long-term (52 weeks) use of hypertension. Eur Heart J 2006;27(Suppl):121 P-797 [7] Chobanian AV, Bakris GL, Black HR et al. and the National High Blood Pressure Education Program Coordinating Committee. The seventh gossip of the Joint National Committee by the tenderloin of avoidance, sighting, evaluation, and treatment of soaring blood pressure. Hypertension 2003; 42:1206-1252 [8] Villamil A, et al. Renin inhibition with aliskiren provides stabilizer antihypertensive efficacy when previously own in combination with hydrochlorothiazide. Journal of Hypertension 2007, 25: 217-226 [9] Boolell M, Glasspool J. Cardiovascular Disease Health Burden, Treatment Benefits and Challenges: Need in support of Partnership. Health & Productivity Management Vol 5, No 4 December 2006, p 11-14.
[10] Tekturna HCT US Prescribing Information [11] Tekturna HCT US Prescribing Information [12] The Lancet: 2007; 370:539 [13] Tekturna/Rasilez® are Novartis trademarks [14] Tekturna/Rasilez® are Novartis trademarks Speedel Holding Ltd
No comments:
Post a Comment